Two key areas of impact
Led by Centre Director, Distinguished Professor Magdalena Plebanski, Research Centre Director Professor Melissa Churchill and Industry Engagement Centre Director Professor Ricky O’Brien, ATRACT will focus on two key areas of impact: ‘Immunity and Infection’ and ‘Cancer Diagnostics and Therapeutics’, with each theme split into three sub-themes.
Plebanski said the Centre aims to achieve impact by streamlining core capabilities in clinical trials, clinical imaging, biobanking, biomarkers and bioinformatics and drug discovery and validation.
“ATRACT achieves global impact by streamlining core capabilities in clinical trials, clinical imaging, biobanking, biomarkers and bioinformatics and drug discovery and validation,” said Plebanski.
Distinguished Professor Arnan Mitchell, Director ARC Centre of Excellence in Optical Microcombs for Breakthrough Science (COMBS), attended the launch of the Centre at RMIT’s Bundoora campus this month. He said he was excited about the multi-disciplinary opportunities presented by the ATRACT Centre.
“As an engineer who works on technology platforms, if I want to create impact, I need to partner with researchers who have important problems to solve,” he said.
“The ATRACT Centre gives me access to clinical researchers working on biomedical problems of global significance - such as ovarian cancer - and gives me and others the opportunity to explore how our technology can really make a difference in these fields.”
“I’m very much looking forward to collaborating with ATRACT and achieving world-changing impact."
Among the industry partners present was the Chief Medical Radiation Scientist for the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), Dr Ivan Williams. He praised ATRACT as a “great example of government collaborating with academia to support research that benefits the economy and society.”
“ARPANSA looks forward to continuing to collaborate with RMIT to bring to life their research to improve radiotherapy,” he said.